Resveratrol Research

Resveratrol, a compound found in red wine and grapes, has garnered significant interest for its potential role in promoting healthy aging. Research suggests resveratrol possesses antioxidant and anti-inflammatory properties, which may contribute to benefits like improved cardiovascular health, blood sugar regulation, and neuroprotection.

While studies in animals and cells have been promising, translating these findings to humans requires further investigation. Current research focuses on optimizing resveratrol's bioavailability (absorption by the body) and confirming its long-term effects in human clinical trials.

At Charava, we closely monitor ongoing research on resveratrol and its potential for promoting healthy aging. We leverage this knowledge to develop and refine our formulations, ensuring we stay at the forefront of scientific discovery.

Below is a list of some of the interesting research and clinical trials on Resveratrol.
For more details, please refer to PubMed.

1. The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials

Published: 2021

This umbrella review evaluates the impact of resveratrol supplementation on cardiometabolic risk factors in individuals with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease.

2. Benefits and Implications of Resveratrol Supplementation: A Systematic Review of In Vitro, In Vivo, and Clinical Studies

Published: 2022

This systematic review explores the effects of resveratrol on human microbiota and its potential therapeutic applications across various medical fields.

3. No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial

Published: 2020

This randomized trial investigates the impact of six months of resveratrol supplementation on insulin sensitivity in overweight individuals.

4. A systematic review and meta-analysis of clinical trials: Resveratrol supplementation in non-alcoholic fatty liver disease

Published: 2020

This meta-analysis assesses the efficacy of resveratrol supplementation in managing non-alcoholic fatty liver disease.

5. Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials

Published: 2018

This review examines the influence of resveratrol on cognitive function and mood in adult populations.

6. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled study

Published: 2014

This study evaluates the effects of resveratrol on inflammatory markers in individuals with nonalcoholic fatty liver disease.

7. Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis

Published: 2020

This meta-analysis investigates the impact of resveratrol on various parameters in patients with non-alcoholic fatty liver disease.

8. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, double-blind, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition

Published: 2013

This clinical trial explores the effects of high-dose resveratrol on metabolism, insulin sensitivity, and body composition in obese men.

9. Resveratrol supplementation: Where are we now and where should we go?

Published: 2015

This review discusses the current state of resveratrol research and suggests directions for future studies.

10. Safety and metabolic outcomes of resveratrol supplementation in overweight older adults: A pilot study

Published: 2014

This pilot study assesses the safety and metabolic effects of resveratrol in overweight older adults.